Randomized Clinical Trial
Copyright ©The Author(s) 2024.
World J Psychiatry. Jul 19, 2024; 14(7): 1087-1094
Published online Jul 19, 2024. doi: 10.5498/wjp.v14.i7.1087
Table 1 Comparison of baseline information between the two groups
Baseline information
Control, n = 76
Observation, n = 76
t/χ2
P value
Age in years55.02 ± 4.0554.59 ± 4.260.6380.525
Disease duration in years3.86 ± 1.144.12 ± 1.301.3110.192
Body mass index in kg/m224.87 ± 0.9525.04 ± 0.920.1210.264
Educational levelHigh school and below49 (64.47)45 (59.21)0.4460.504
Above high school27 (35.53)31 (40.79)
Table 2 Comparison of symptom improvement between the two groups
Content
Time
Control, n = 76
Observation, n = 76
t value
P value
Hot flashes and sweatingPre-treatment8.35 ± 1.278.20 ± 1.320.7140.476
Post-treatment4.24 ± 1.18a3.78 ± 1.09a2.4960.014
Abnormal sensationsPre-treatment3.52 ± 0.473.43 ± 0.501.1430.255
Post-treatment2.05 ± 0.36a1.93 ± 0.24a2.4180.017
InsomniaPre-treatment3.23 ± 0.613.35 ± 0.581.2430.216
Post-treatment2.14 ± 0.43a1.98 ± 0.32a2.6020.010
AgitationPre-treatment3.12 ± 0.453.03 ± 0.371.3470.180
Post-treatment1.69 ± 0.28a1.60 ± 0.15a2.4700.015
DepressionPre-treatment1.87 ± 0.361.90 ± 0.420.4730.637
Post-treatment1.15 ± 0.19a1.09 ± 0.10a2.4360.016
VertigoPre-treatment1.41 ± 0.291.38 ± 0.270.6600.510
Post-treatment1.01 ± 0.17a0.95 ± 0.08a2.7840.006
Bone and joint pain/muscle painPre-treatment1.93 ± 0.351.87 ± 0.400.9840.327
Post-treatment1.31 ± 0.22a1.24 ± 0.09a2.5670.011
HeadachesPre-treatment1.61 ± 0.531.58 ± 0.600.3270.744
Post-treatment1.02 ± 0.34a0.90 ± 0.23a2.5490.012
FatiguePre-treatment1.73 ± 0.421.68 ± 0.370.7790.437
Post-treatment1.19 ± 0.30a1.08 ± 0.24a2.4960.014
PalpitationsPre-treatment1.49 ± 0.381.52 ± 0.430.4560.649
Post-treatment0.83 ± 0.25a0.74 ± 0.19a2.4990.014
Crawling sensation of the skinPre-treatment1.17 ± 0.261.22 ± 0.301.0980.274
Post-treatment0.73 ± 0.18a0.67 ± 0.10a2.5400.012
SexualityPre-treatment3.47 ± 0.583.38 ± 0.610.9320.353
Post-treatment2.03 ± 0.35a1.90 ± 0.24a2.6710.008
Urinary tract infectionPre-treatment3.02 ± 0.493.06 ± 0.540.4780.633
Post-treatment1.88 ± 0.36a1.75 ± 0.27a2.5180.013
Table 3 Comparison between emotional states observed in the two groups
GroupnPositive emotions
Negative emotions
Pre-treatment
Post-treatment
Pre-treatment
Post-treatment
Control7620.45 ± 5.2332.79 ± 5.46a34.58 ± 5.6922.81 ± 5.37a
Observation7620.59 ± 5.3735.08 ± 5.54a34.23 ± 5.7220.64 ± 5.15a
t value0.1632.5670.3782.543
P value0.8710.0110.7060.012
Table 4 Comparison between sleep quality of the two groups
GroupnInsufficient sleep
Poor quality of sleep
Insufficient sleep or wakefulness
Sleep duration
Difficulty in sleeping
Pre-treatment
Post-treatment
Pre-treatment
Post-treatment
Pre-treatment
Post-treatment
Pre-treatment
Post-treatment
Pre-treatment
Post-treatment
Control763.47 ± 0.812.21 ± 0.53a2.91 ± 0.672.08 ± 0.35a3.08 ± 0.722.39 ± 0.48a2.84 ± 0.522.02 ± 0.31a2.69 ± 0.401.77 ± 0.24a
Observation763.52 ± 0.792.02 ± 0.38a2.88 ± 0.701.96 ± 0.23a3.11 ± 0.692.22 ± 0.31a2.90 ± 0.571.91 ± 0.24a2.73 ± 0.461.69 ± 0.15a
t value0.3852.5400.2702.4980.2622.5940.6782.4460.5722.464
P value0.7010.0120.7880.0140.7930.0100.4990.0160.5680.015
Table 5 Comparison of treatment effectiveness between the two groups
Group
n
Curable
Conspicuous effect
Efficiently
Null
Overall effectiveness of treatment
Control7620 (26.32)29 (38.16)17 (22.37)10 (13.16)66 (86.84)
Observation7624 (31.58)30 (39.47)19 (25.00)3 (3.95)73 (96.05)
χ24.121
P value0.042
Table 6 Comparison between treatment safety in the two groups
Group
n
Nausea and vomiting
Breast swelling and pain
Irregular vaginal bleeding
Incidence of adverse reactions
Control762 (2.63)1 (1.32)2 (2.63)5 (6.58)
Observation762 (2.63)3 (3.95)2 (2.63)7 (9.21)
χ20.361
P value0.547